Cogstate Ltd(COGZF)
$2.43-0.13 (-5.26%)
COGZF
Cogstate Ltd stock drug pipeline
$2.43
At close:-0.13 (-5.26%)
Cogstate Ltd (COGZF) Drug Pipeline
10 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Nyx-458 | Parkinson Disease, Mild Cognitive Impairment, Mild Dementia, Lewy Body Disease | Phase II | Active Not Recruiting | NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's Disease or Lewy Body Dementia (Cognition, Memory, Attention, Thinking) | Oct 30, 2019 | ― |
| Abx-1431 | Tourette Syndrome, Motor Tic Disorder | Phase II | Completed | Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder | Aug 08, 2018 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Nyx-458 | Phase II | Parkinson Disease, Mild Cognitive Impairment, Mild Dementia, Lewy Body Disease | Active Not Recruiting | NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's Disease or Lewy Body Dementia (Cognition, Memory, Attention, Thinking) | Oct 30, 2019 | ― |
| Abx-1431 | Phase II | Tourette Syndrome, Motor Tic Disorder | Completed | Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder | Aug 08, 2018 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Cogstate Ltd (COGZF) have in its pipeline
Cogstate Ltd COGZF is currently developing the following drugs: Nyx-458, Abx-1431. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
